论文部分内容阅读
目的:探讨分析替米沙坦治疗糖尿病合并高血压的临床效果。方法:选择我院2013年1月~2014年1月住院糖尿病合并高血压患者120例,随机分为对照组和治疗组,每组各60例。对照组采用注射胰岛素与口服卡托普利片进行治疗,治疗组采用注射胰岛素与口服替米沙坦进行治疗,治疗1个月后,观察比较两组临床疗效以及监测心功能指标变化情况。结果:患者经过1个月治疗后,治疗组的总有效率为96.7%,对照组的总有效率为85.0%,治疗组总有效率明显高于对照组,差异有统计学意义(P<0.05);治疗组的超声E值明显高于对照组,而A值明显低于对照组,差异具有统计学意义(P<0.05)。结论:替米沙坦治疗糖尿病合并高血压可以取得比较显著的临床效果,值得临床上推广并使用。
Objective: To investigate the clinical effect of telmisartan in the treatment of diabetes complicated with hypertension. Methods: A total of 120 hospitalized diabetic patients with hypertension were selected from January 2013 to January 2014 in our hospital. They were randomly divided into control group and treatment group, 60 cases in each group. The control group was treated with insulin and oral captopril. The treatment group was treated with insulin and oral telmisartan. One month after treatment, the clinical efficacy and the monitoring of cardiac function were observed and compared. Results: After one month treatment, the total effective rate of the treatment group was 96.7% and that of the control group was 85.0%. The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05 ); The E value of the treatment group was significantly higher than that of the control group, and the A value was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion: Telmisartan treatment of diabetes with hypertension can achieve more significant clinical results, it is worth to promote and use in clinical.